GLOBAL RESEARCH SYNDICATE
No Result
View All Result
  • Login
  • Latest News
  • Consumer Research
  • Survey Research
  • Marketing Research
  • Industry Research
  • Data Collection
  • More
    • Data Analysis
    • Market Insights
  • Latest News
  • Consumer Research
  • Survey Research
  • Marketing Research
  • Industry Research
  • Data Collection
  • More
    • Data Analysis
    • Market Insights
No Result
View All Result
globalresearchsyndicate
No Result
View All Result
Home Data Analysis

Hospitalizations for IBD Among Medicare Beneficiaries

globalresearchsyndicate by globalresearchsyndicate
December 30, 2019
in Data Analysis
0
Hospitalizations for IBD Among Medicare Beneficiaries
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Table.  Hospitalizations for inflammatory bowel disease (IBD)* as the principal diagnosis among Medicare fee-for-service beneficiaries,
† by age, sex, race/ethnicity, and urban-rural status of residence — United States, 2017
Characteristic No. of hospitalizations Hospitalization rate,§ (95% CI) Surgery rate,¶,**,†† (95% CI) 30-Day readmission rate,¶,§§ (95% CI) 30-Day mortality rate,¶,¶¶ (95% CI) Length of stay (days)** geometric mean,*** (95% CI)
Crohn’s disease†††
Total 4,782 15.5 (15.0–15.9) 17.4 (16.3–18.4) 15.8 (14.5–17.1) 2.7 (2.2–3.1) 3.9 (3.8–4.0)
Age group (yrs)
65–74 2,912 17.1 (16.5–17.7) 19.3 (17.8–20.7) 15.4 (13.7–17.0) 1.7 (1.2–2.1) 3.8 (3.7–3.9)
≥75 1,870 13.7 (13.1–14.4) 14.4 (12.8–16.0) 16.5 (14.3–18.7) 4.2 (3.3–5.1) 4.1 (3.9–4.2)
Sex
Men 2,001 14.1 (13.5–14.8) 19.0 (17.3–20.8) 17.6 (15.5–19.7) 3.0 (2.3–3.8) 3.8 (3.6–3.9)
Women 2,781 16.7 (16.1–17.3) 16.1 (14.8–17.5) 14.5 (12.7–16.1) 2.4 (1.8–3.0) 4.0 (3.9–4.1)
Race/Ethnicity
White, non-Hispanic 4,227 16.9 (16.4–17.5) 17.5 (16.4–18.7) 16.1 (14.6–17.5) 2.6 (2.1–3.0) 4.0 (3.9–4.0)
Black, non-Hispanic 250 10.3 (9.0–11.5) 10.8 (7.0–14.6) 14.7 (9.1–20.2) —§§§ 4.2 (4.0–4.5)
Other or unknown¶¶¶ 305 8.8 (7.8–9.8) 20.3 (15.8–24.8) 13.1 (8.3–17.7) —§§§ 4.1 (3.8–4.3)
Beneficiary residence****
Urban 3,938 16.0 (15.5–16.5) 17.0 (15.8–18.2) 16.1 (14.6–17.5) 2.6 (2.1–3.1) 3.9 (3.8–4.0)
Rural 844 13.4 (12.5–14.3) 19.0 (16.3–21.6) 14.5 (11.3–17.7) 3.1 (1.9–4.3) 3.8 (3.7–4.0)
Ulcerative colitis†††
Total 4,932 16.2 (15.8–16.7) 11.2 (10.3–12.1) 16.0 (14.6–17.3) 3.8 (3.3–4.4) 4.1 (4.0–4.2)
Age group (yrs)
65–74 2,395 14.1 (13.5–14.6) 15.6 (14.1–17.0) 14.5 (12.7–16.3) 2.1 (1.5–2.7) 4.1 (4.0–4.3)
≥75 2,537 18.6 (17.9–19.4) 7.0 (6.0–8.0) 17.4 (15.5–19.3) 5.5 (4.6–6.4) 4.0 (3.9–4.2)
Sex
Men 1,872 13.5 (12.9–14.2) 16.9 (15.2–18.6) 17.6 (15.3–19.8) 4.0 (3.1–4.9) 4.2 (4.1–4.4)
Women 3,060 18.4 (17.7–19.0) 7.6 (6.7–8.6) 15.0 (13.4–16.6) 3.7 (3.1–4.4) 4.0 (3.9–4.1)
Race/Ethnicity
White, non-Hispanic 4,205 17.0 (16.5–17.5) 11.5 (10.6–12.5) 16.0 (14.6–17.4) 4.0 (3.4–4.6) 4.0 (3.9–4.0)
Black, non-Hispanic 325 14.0 (12.4–15.5) 7.1 (4.3–9.9) 18.9 (13.5–24.1) —§§§ 4.2 (4.0–4.5)
Other or unknown¶¶¶ 402 12.0 (10.8–13.3) 10.7 (7.7–13.7) 13.2 (8.9–17.4) —§§§ 4.1 (3.8–4.3)
Beneficiary residence****
Urban 4,110 17.0 (16.5–17.6) 10.8 (9.9–11.8) 16.2 (14.7–17.6) 3.9 (3.3–4.5) 4.1 (4.0–4.2)
Rural 819 13.2 (12.2–14.1) 12.9 (10.6–15.2) 14.9 (11.5–18.1) 3.4 (2.2–4.7) 4.0 (3.8–4.2)

Abbreviation: CI = confidence interval.
*IBD encompasses Crohn’s disease and ulcerative colitis.
†The number of eligible Medicare beneficiaries aged ≥65 years in 2017 in the United States was approximately 30,658,000.
§Hospitalizations per 100,000 Medicare enrollees, age-adjusted to the 2000 U.S. Standard Population aged ≥65 years based on two age groups (65–74 years and ≥75 years), except for age-specific analysis. https://www.cdc.gov/nchs/data/statnt/statnt20.pdf.
¶Per 100 hospital stays.
**The denominator is number of hospital admissions. To calculate surgery rate and geometric mean of length of stay, n = 4,782 for Crohn’s disease and n = 4,932 for ulcerative colitis.
†† International Classification of Diseases, Tenth Edition, Procedure Coding System procedure codes involving small and large intestine include partial resection (0DB80ZZ, 0DB90ZZ, 0DBA0ZZ, 0DBB0ZZ, 0DBC0ZZ, 0DBE0ZZ, 0DBF0ZZ, 0DBG0ZZ, 0DBH0ZZ, 0DBK0ZZ, 0DBL0ZZ, 0DBM0ZZ, 0DBN0ZZ, 0DBP0ZZ, 0DB83ZZ, 0DB93ZZ, 0DBA3ZZ, 0DBB3ZZ, 0DBC3ZZ, 0DBE3ZZ, 0DBF3ZZ, 0DBG3ZZ, 0DBH3ZZ, 0DBK3ZZ, 0DBL3ZZ, 0DBM3ZZ, 0DBN3ZZ, 0DBP3ZZ, 0DB84ZZ, 0DB94ZZ, 0DBA4ZZ, 0DBB4ZZ, 0DBC4ZZ, 0DBE4ZZ, 0DBF4ZZ, 0DBG4ZZ, 0DBH4ZZ, 0DBK4ZZ, 0DBL4ZZ, 0DBM4ZZ, 0DBN4ZZ, 0DBP4ZZ, 0DB87ZZ, 0DB97ZZ, 0DBA7ZZ, 0DBB7ZZ, 0DBC7ZZ, 0DBE7ZZ, 0DBF7ZZ, 0DBG7ZZ, 0DBH7ZZ, 0DBK7ZZ, 0DBL7ZZ, 0DBM7ZZ, 0DBN7ZZ, 0DBP7ZZ, 0DB88ZZ, 0DB98ZZ, 0DBA8ZZ, 0DBB8ZZ, 0DBC8ZZ, 0DBE8ZZ, 0DBF8ZZ, 0DBG8ZZ, 0DBH8ZZ, 0DBK8ZZ, 0DBL8ZZ, 0DBM8ZZ, 0DBN8ZZ, 0DBP8ZZ) and total resection (0DT80ZZ, 0DT90ZZ, 0DTA0ZZ, 0DTB0ZZ, 0DTC0ZZ, 0DTE0ZZ, 0DTF0ZZ, 0DTG0ZZ, 0DTH0ZZ, 0DTK0ZZ, 0DTL0ZZ, 0DTM0ZZ, 0DTN0ZZ, 0DTP0ZZ, 0DT84ZZ, 0DT94ZZ, 0DTA4ZZ, 0DTB4ZZ, 0DTC4ZZ, 0DTE4ZZ, 0DTF4ZZ, 0DTG4ZZ, 0DTH4ZZ, 0DTK4ZZ, 0DTL4ZZ, 0DTM4ZZ, 0DTN4ZZ, 0DTP4ZZ, 0DT87ZZ, 0DT97ZZ, 0DTA7ZZ, 0DTB7ZZ, 0DTC7ZZ, 0DTE7ZZ, 0DTF7ZZ, 0DTG7ZZ, 0DTH7ZZ, 0DTK7ZZ, 0DTL7ZZ, 0DTM7ZZ, 0DTN7ZZ, 0DTP7ZZ, 0DT88ZZ, 0DT98ZZ, 0DTA8ZZ, 0DTB8ZZ, 0DTC8ZZ, 0DTE8ZZ, 0DTF8ZZ, 0DTG8ZZ, 0DTH8ZZ, 0DTK8ZZ, 0DTL8ZZ, 0DTM8ZZ, 0DTN8ZZ, 0DTP8ZZ).§§30-day readmission rate was calculated as the number of all-cause readmissions to acute care, nonfederal hospitals within 30 days from the discharge date associated with an index admission per 100 stays. Index admissions were nonfederal acute-care hospital admissions with Crohn’s disease or ulcerative colitis as the principal diagnosis, had a live discharge, and had a routine discharge to home or skilled nursing facility. To ensure the calculation of the complete 30-day readmission, index admissions with discharge date in December 2017 were excluded. Readmissions were defined as all-cause acute admissions whose discharge destinations were not against medical advice or expired. Multiple readmissions within the 30-day time frame from one index admission were counted as one readmission. A readmission from a previous index admission could be also counted as a new index admission if it met the selection criteria for an index admission (https://www.medicare.gov/hospitalcompare/data/30-day-measures.html). To calculate 30-day all-cause readmission rate, n = 3,022 for Crohn’s disease; n = 3,060 for ulcerative colitis.
¶¶30-day mortality rate was defined as number of all-cause deaths occurred within 30 days from IBD-related admissions per 100 hospital stays. Hospitalizations were excluded if patients were discharged against medical advice. More information is available at https://www.medicare.gov/hospitalcompare/data/30-day-measures.html. To calculate 30-day all-cause readmission rate, n = 4,781 for Crohn’s disease; n = 4,932 for ulcerative colitis.
***Geometric mean is the xth root of the product of the length of stay (days) from x patients (x indicates the number of patients), which, because it is not influenced by outliers, is used here rather than arithmetic mean.
††† International Classification of Diseases, Tenth Edition, Clinical Modification diagnosis codes K50 (Crohn’s disease) and K51 (ulcerative colitis).
§§§Data were suppressed according to the cell size suppression (https://www.resdac.org/articles/cms-cell-size-suppression-policy) or if the relative standard error was >0.3.
¶¶¶Other includes Hispanic, Asian, Native American, and all others.
****Urban areas include large metro, large fringe metro, medium metro, or small metro. Rural areas include micropolitan and noncore. The definition is based on 2013 National Center for Health Statistics Urban-Rural Classification Scheme for Counties (https://www.cdc.gov/nchs/data/series/sr_02/sr02_166.pdf).

Related Posts

How Machine Learning has impacted Consumer Behaviour and Analysis
Consumer Research

How Machine Learning has impacted Consumer Behaviour and Analysis

January 4, 2024
Market Research The Ultimate Weapon for Business Success
Consumer Research

Market Research: The Ultimate Weapon for Business Success

June 22, 2023
Unveiling the Hidden Power of Market Research A Game Changer
Consumer Research

Unveiling the Hidden Power of Market Research: A Game Changer

June 2, 2023
7 Secrets of Market Research Gurus That Will Blow Your Mind
Consumer Research

7 Secrets of Market Research Gurus That Will Blow Your Mind

May 8, 2023
The Shocking Truth About Market Research Revealed!
Consumer Research

The Shocking Truth About Market Research: Revealed!

April 25, 2023
market research, primary research, secondary research, market research trends, market research news,
Consumer Research

Quantitative vs. Qualitative Research. How to choose the Right Research Method for Your Business Needs

March 14, 2023
Next Post
Agriculture Stall Mats Market to Reflect Significant Growth Prospects During 2019–2023

Agriculture Stall Mats Market to Reflect Significant Growth Prospects During 2019–2023

Categories

  • Consumer Research
  • Data Analysis
  • Data Collection
  • Industry Research
  • Latest News
  • Market Insights
  • Marketing Research
  • Survey Research
  • Uncategorized

Recent Posts

  • Ipsos Revolutionizes the Global Market Research Landscape
  • How Machine Learning has impacted Consumer Behaviour and Analysis
  • Market Research: The Ultimate Weapon for Business Success
  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA

Copyright © 2024 Globalresearchsyndicate.com

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
No Result
View All Result
  • Latest News
  • Consumer Research
  • Survey Research
  • Marketing Research
  • Industry Research
  • Data Collection
  • More
    • Data Analysis
    • Market Insights

Copyright © 2024 Globalresearchsyndicate.com